Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study
On October 3, Oppenheimer reaffirmed its Outperform rating on Amgen Inc. (NASDAQ:AMGN) with a price target of $380.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 48,209 | $13,604,580 | -3% | 0.3% |
| 2. | Lee Munder Capital Group Lee Munder | 32,770 | $9,247,694 | -1% | 0.54% |
| 3. | Zevenbergen Capital Investments Nancy Zevenbergen | 9,909 | $2,796,320 | +1% | 0.05% |
| 4. | Bourgeon Capital John Zaro | 3,395 | $958,069 | -1% | 0.17% |
| 5. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 1,725 | $486,795 | +15% | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | $1,655.00 | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | $499,907.10 | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | $99,919.25 | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $296.99 | 1,267 | $376,280.00 | 7,209 | 2025-08-20 | Filing | |
| $289.68 | 1,500 | $434,520.00 | 8,162 | 2025-06-05 | Filing | |
| $279.69 | 1,000 | $279,690.00 | 4,034 | 2025-05-02 | Filing | |
| $292.84 | 8,711 | $2,550,903.11 | 71,546 | 2025-02-19 | Filing | |
| $304.44 | 25,225 | $7,679,524.23 | 36,922 | 2025-02-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,979,186 | $1,122,926,243 | 0.2% | |
| 2. | 2,874,403 | $794,456,246 | 0.7% | |
| 3. | 2,087,554 | $589,107,925 | 1.04% | |
| 4. | 1,656,072 | $467,343,518 | 0.27% | |
| 5. | 1,613,121 | $455,222,746 | 1.15% |
News See All
11 Defensive Healthcare Dividend Stocks To Buy Now
US healthcare stocks have been under mounting pressure this year, largely due to policies introduced by the Trump administration.
Amgen (AMGN) Announces Launch of AmgenNow
Amgen Inc. (NASDAQ:AMGN) is one of the Best Wide Moat Stocks to Buy Right Now. The company possesses a wide economic moat, which is backed by its intellectual property and brand reputation.
11 Best Wide Moat Stocks to Buy Right Now
As per S&P Global, the US policy uncertainty, while declining, continues to impact the global macro picture. The firm also opines that recent global macro data remains somewhat stronger than expected.
Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention
Amgen Inc. (NASDAQ:AMGN) is one of the best growth stocks to buy now.
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right now.
Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion
Amgen Inc. (NASDAQ:AMGN) ranks among the top picks for a retirement portfolio. On September 26, Amgen Inc.
Retirement Stock Portfolio: Top 15 Stock Picks
The Federal Reserve is decreasing its benchmark rate after holding them stable for most of the year despite President Donald Trump's demands to do so.
Top 12 Blue Chip Stocks to Buy At 52-Week Lows
On September 30, Elyse Ausenbaugh, Head of Investment Strategy at JPMorgan Wealth Management, joined CNBC for an interview to discuss the current market rally.
Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)
Amgen Inc. (NASDAQ:AMGN) is one of the best large cap value stocks to buy now. On September 26, Bank of America Securities analyst Tim Anderson maintained a Sell rating on Amgen Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
